Drug maker Alkem Laboratories has reported a growth of 24.9 per cent in its consolidated net profit at Rs 233.40 crore for the October-December quarter of 2016, helped by healthy growth in key markets of India and US amidst tough business environment. The pharmaceutical company had posted the consolidated net profit of Rs 186.90 crore in the corresponding quarter of previous fiscal, said Alkem Laboratories in a filing to BSE on Friday.
The consolidated total revenue of company rose by 15.1 per cent to Rs 1,481.90 crore in Q3 FY17 from Rs 1,287.80 crore in Q3 FY16. India sales contributed 70.4 per cent to total sales at Rs 1,029.80 for Q3FY17.
Costumer’s profit is one of our main motive and we are here with a lots of risk free services so click here for more http://www.ripplesadvisory.com/free-trial.php
Drug maker Alkem Laboratories has reported a growth of 24.9 per cent in its consolidated net profit at Rs 233.40 crore for the October-December quarter of 2016, helped by healthy growth in key markets of India and US amidst tough business environment. The pharmaceutical company had posted the consolidated net profit of Rs 186.90 crore in the corresponding quarter of previous fiscal, said Alkem Laboratories in a filing to BSE on Friday. 
No comments:
Post a Comment